BackgroundRecent proteomic studies have documented that Long COVID in adults is characterized by a pro-inflammatory signature with thromboinflammation. However, if similar events happen also in children with Long COVID has never been investigated.MethodsWe performed an extensive protein analysis of blood plasma from pediatric patients younger than 19 years of age Long COVID and a control group of children with acute COVID-19, MIS-C, and healthy controls resulted similar for sex distribution and age. Children were classified as Long COVID if symptoms persisted for at least 8 weeks since the initial infection, negatively impacted daily life and could not be explained otherwise.Results112 children were included in the study, including 34 children fulfilling clinical criteria of Long COVID, 32 acute SARS-CoV-2 infection, 27 MIS-C and 19 healthy controls. Compared with controls, pediatric Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a. A Machine Learning model based on proteomic profile was able to identify LC with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.ConclusionsPediatric Long COVID patients have a well distinct blood protein signature marked by increased ongoing general and endothelial inflammation, similarly as happens in adults.ImpactPediatric Long COVID has a distinct blood protein signature marked by increased ongoing general and endothelial inflammation.This is the first study studying and documenting proinflammatory profile in blood samples of children with long COVID.Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a.A proteomic profile was able to identify Long COVID with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.These findings may inform development of future diagnostic tests.

Buonsenso, D., Cotugno, N., Amodio, D., Pascucci, G.r., Di Sante, G., Pighi, C., et al. (2025). Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls. PEDIATRIC RESEARCH [10.1038/s41390-025-03837-0].

Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Cotugno N.;Amodio D.;Pascucci G. R.;Morrocchi E.;Olivieri G.;Colantoni N.;Rotili A.;Neri A.;
2025-01-01

Abstract

BackgroundRecent proteomic studies have documented that Long COVID in adults is characterized by a pro-inflammatory signature with thromboinflammation. However, if similar events happen also in children with Long COVID has never been investigated.MethodsWe performed an extensive protein analysis of blood plasma from pediatric patients younger than 19 years of age Long COVID and a control group of children with acute COVID-19, MIS-C, and healthy controls resulted similar for sex distribution and age. Children were classified as Long COVID if symptoms persisted for at least 8 weeks since the initial infection, negatively impacted daily life and could not be explained otherwise.Results112 children were included in the study, including 34 children fulfilling clinical criteria of Long COVID, 32 acute SARS-CoV-2 infection, 27 MIS-C and 19 healthy controls. Compared with controls, pediatric Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a. A Machine Learning model based on proteomic profile was able to identify LC with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.ConclusionsPediatric Long COVID patients have a well distinct blood protein signature marked by increased ongoing general and endothelial inflammation, similarly as happens in adults.ImpactPediatric Long COVID has a distinct blood protein signature marked by increased ongoing general and endothelial inflammation.This is the first study studying and documenting proinflammatory profile in blood samples of children with long COVID.Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a.A proteomic profile was able to identify Long COVID with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.These findings may inform development of future diagnostic tests.
2025
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/38
Settore MEDS-20/A - Pediatria generale e specialistica
Settore MEDS-10/B - Malattie infettive
English
Con Impact Factor ISI
https://www.nature.com/articles/s41390-025-03837-0
Buonsenso, D., Cotugno, N., Amodio, D., Pascucci, G.r., Di Sante, G., Pighi, C., et al. (2025). Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls. PEDIATRIC RESEARCH [10.1038/s41390-025-03837-0].
Buonsenso, D; Cotugno, N; Amodio, D; Pascucci, Gr; Di Sante, G; Pighi, C; Morrocchi, E; Pucci, A; Olivieri, G; Colantoni, N; Romani, L; Rotili, A; Ner...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
s41390-025-03837-0.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright degli autori
Dimensione 930.25 kB
Formato Adobe PDF
930.25 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/409784
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact